Precipitation in and supersaturation of contents of the upper small intestine after administration of two weak bases to fasted adults

Pharm Res. 2011 Dec;28(12):3145-58. doi: 10.1007/s11095-011-0506-6. Epub 2011 Jun 15.

Abstract

Purpose: To evaluate precipitation in and supersaturation of intestinal contents after administration of pharmacologically relevant doses of dipyridamole and ketoconazole to 12 healthy adults.

Methods: On two separate days each subject was administered in stomach 240 ml aqueous solutions of two dipyridamole doses (30/90 mg) and two ketoconazole doses (100/300 mg). Physicochemical characteristics, total drug content, and drug concentration were measured in individual intestinal contents (≤7 ml) aspirated at specific times post-dosing. Drug concentration after incubation (37°C/48 h) and equilibrium solubility were measured. Precipitate crystallinity was evaluated by x-ray powder diffraction.

Results: Precipitated fraction was minimal (dipyridamole, ≤7%) or limited (ketoconazole, ≤16%). Ketoconazole precipitates were mostly amorphous. Depending on dose, intestinal contents with pH > 3.6 were supersaturated with dipyridamole up to 10 and 30 min and with ketoconazole up to 30 and 50 min post-administration. Intestinal contents with pH > 5 and concentration of micellar components <5 mM were supersaturated with ketoconazole or dipyridamole, but precipitated fraction was significant only for ketoconazole. After incubation, crystalline precipitates were found in almost all samples. Slow precipitation of base and/or precipitation of other phases account for this observation.

Conclusions: Intralumenal precipitation of weakly alkaline, lipophilic, high permeability drugs may not be substantial. Estimating intestinal supersaturation in regard to free base is inadequate as other phases may precipitate.

MeSH terms

  • Adult
  • Antifungal Agents / chemistry
  • Antifungal Agents / pharmacokinetics*
  • Chemical Precipitation
  • Dipyridamole / chemistry
  • Dipyridamole / pharmacokinetics*
  • Fasting
  • Female
  • Gastrointestinal Contents / chemistry*
  • Humans
  • Intestine, Small / chemistry*
  • Ketoconazole / chemistry
  • Ketoconazole / pharmacokinetics*
  • Male
  • Phosphodiesterase Inhibitors / chemistry
  • Phosphodiesterase Inhibitors / pharmacokinetics*
  • Solubility
  • Young Adult

Substances

  • Antifungal Agents
  • Phosphodiesterase Inhibitors
  • Dipyridamole
  • Ketoconazole